StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3633.T$1680.00-0.30%
Fair $1680.00+0.0%

3633.T

GMO Pepabo, Inc.

Technology / Software - InfrastructureTokyo

$1680.00

-5.00 (-0.30%)

Fairly Valued+0.0%Fair Value $1680.00Fund rank 27/100 · Data gapFallback financials|
SA 49/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 22%

FCF escenarios

weak_data · normalized FCF $1.3B · quality 41.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3633.TLocal privado en este navegador · GMO Pepabo, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.7B

P/E

10.0x

↓

EV/EBITDA

4.2x

↓

ROE

31.4%

↑

Gross Margin

54.4%

↑

Debt/Equity

0.31

↑
52-Week Range$1680
$1444$2675

TradingView lightweight chart

3633.T price, volumen y niveles de valoración

Último $1,680Periodo +76.8%
Fair value: $1,680

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+1.3%

FCF CAGR

—

FCF margin

11.5%

FCF / Net income

1.44x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.96B · net income $878.4M · FCF $1.27B

2022-FY → 2025-FY

Gross margin

54.4%-3.3% pts

Operating margin

8.5%+1.6% pts

Net margin

8.0%+3.2% pts

FCF margin

11.5%+18.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$10.96B$10.96B$10.92B$10.90B$10.53B
Net Income$878.4M$878.4M$591.6M$-628.8M$510.1M
EBITDA$1.78B$1.78B$1.47B$72.1M$1.12B
EPS——112.12-119.1696.37
Gross Margin54.4%54.4%52.9%54.4%57.7%
Operating Margin8.5%8.5%7.6%-3.1%7.0%
Net Margin8.0%8.0%5.4%-5.8%4.8%
Balance Sheet
Debt/Equity0.310.310.500.820.58
Current Ratio1.131.13———
Cash Flow
Free Cash Flow$1.27B$1.27B$901.2M$1.38B$-708.9M
Returns
ROE31.4%31.4%24.8%-34.7%19.0%
Valuation
P/E9.969.9613.41—19.81
EV/EBITDA4.164.164.2868.808.12
P/B3.133.133.323.453.76
Growth & Yield
Revenue Growth0.3%0.3%0.2%3.5%—
EPS Growth——194.1%-223.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +9.1%

Total return

+9.1%

Start / end P/E

n/dx → n/dx

EPS bridge

112.12 → n/d

Residual

+9.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+9.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.